Morwan Osman
@morwan.me
Mycobacteriologist and Postdoctoral Fellow in the York Bioenergetics Lab, University Of York (@jnb-lab.bsky.social).
Formerly: @pembroke1347.bsky.social & @mrclmb.bsky.social. @mcbseattle.bsky.social PhD.
Formerly: @pembroke1347.bsky.social & @mrclmb.bsky.social. @mcbseattle.bsky.social PhD.
Reposted by Morwan Osman
I presented our preclinical work on the BNT164 #Tuberculosis candidates. This work is now also available as a preprint!
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
mRNA-based tuberculosis vaccines BNT164a1 and BNT164b1 are immunogenic, well-tolerated and efficacious in rodent models
We designed and preclinically tested two mRNA-LNP-based vaccine candidates to protect against tuberculosis (TB). BNT164a1 and BNT164b1 encode the same eight Mycobacterium tuberculosis ( Mtb ) antigens...
www.biorxiv.org
November 12, 2025 at 12:54 PM
I presented our preclinical work on the BNT164 #Tuberculosis candidates. This work is now also available as a preprint!
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...